Choosing the readout before the plate in in vitro toxicology testing: why an mts assay reports metabolic activity rather than cell number and what that hides, where a fluorescent cell counter settles the question a viability dye only implies, what cell painting and multiplex immunofluorescence buy in mechanism at the cost of an analysis pipeline, how a toxicology lab and the toxicology labs you might use instead differ in what they will sign, and what toxicology lab equipment is actually needed in house

Designing the assay

1. State the question as an endpoint. Is the question whether cells die, whether they stop dividing, or whether a pathway is perturbed? Those are three different endpoints and three different assays, and a single viability number cannot distinguish them.
2. Know what each dye actually reports. Tetrazolium reduction reports metabolic activity. Nucleic acid exclusion dyes report membrane integrity. Protease and ATP based assays report other proxies again. Compounds that affect metabolism directly will confound the first without killing anything.
3. Run a time course before fixing a timepoint. Toxicity develops, and a single endpoint chosen for convenience can sit before or after the effect. One time course experiment makes every subsequent single timepoint interpretable.
4. Control for compound interference. Coloured and fluorescent compounds interfere with plate readouts directly. Include compound only wells without cells, and check for absorbance or fluorescence at the read wavelength before concluding anything.
5. Decide whether imaging is worth its pipeline. High content imaging gives per cell information and mechanistic detail, and it brings an analysis burden that has to be resourced. Buy it when the mechanism matters, not because it produces more data.
6. Decide in house against a contract laboratory. Where results must be signed under a quality system, a contract laboratory brings the system, the trained staff and the documentation. In house work suits screening and mechanism where speed and iteration matter more.

Proxies and what they miss

A compound that inhibits mitochondrial function will reduce a metabolic readout dramatically while leaving cells alive and recoverable. A compound that arrests division will reduce total signal in any assay that scales with cell number, without killing anything. Both are commonly reported as toxicity.

Running one metabolic and one integrity assay, plus a count on the hits, resolves nearly all of these ambiguities and costs one extra plate.

Plate effects are the other half of the noise

Evaporation at the edges, uneven seeding and gradients in the incubator all produce patterns that look like dose responses. Randomising treatment position across the plate and using inner wells for the samples that matter removes most of it.

Include a uniformity plate in method development: same cells, same treatment, every well. The pattern it reveals will inform every plate layout afterwards.

Common questions

Why do my viability assays disagree?

Because they measure different things. Metabolic assays respond before cell death and can be affected directly by the compound; membrane integrity assays report a late event. Disagreement is information rather than a fault, and running two is often the right answer.

Is counting cells better?

It is closer to the endpoint most people mean, and it distinguishes reduced proliferation from cell death, which single dye assays cannot. It costs more effort per plate, which is why it is often reserved for confirming a hit.

When is high content imaging justified?

When the mechanism of the effect matters, when subpopulations are important, or when several endpoints must be measured on the same cells. It is not justified simply because a plate reader seems limited.

Do these assays predict in vivo toxicity?

Partially and inconsistently, which is why they are used for ranking and mechanism rather than for prediction. Being explicit about that in the study report avoids the result being over interpreted later.

Browse by service class

• Compare Gene synthesis on advertised prices